Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02310490 · ClinicalTrials.gov registry record · NA
DA-13-007 Versus Sculptra for the Treatment of Nasolabial Folds Wrinkles
A NA study of Face; Atrophy, sponsored by DermAvance.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
- 4
- Study locations
NCT02310490 is a NA study of Face; Atrophy that has completed, run by DermAvance. The registered enrollment target is 161 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT02310490, a NA study of Face; Atrophy, has completed, sponsored by DermAvance.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
- 4
- Study locations
Study Summary
Study DA-13-007 is a randomized, evaluator-blinded, within subject (split face) multicenter clinical study of DA-13-007l (Injectable poly-l-lactic acid) compared to SCULPTRA in the treatment of nasolabial fold wrinkles. Qualifying subjects will be randomized to receive DA-13-007l and SCULPTRA on either the right or left side of the face.
Conditions Studied
Interventions
- DEVICE DA-13-007 right with left side Sculptra left side
- DEVICE DA-13-007 left with left side Sculptra right side
Study Locations (4)
Florida
- Bay Area Dermatology - Bradenton
- Miami Skin Institute - Coral Gables
Indiana
- Laser & Skin Surgery Center of Indiana - Carmel
Washington
- PCR - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02310490
The ClinicalTrials.gov registry entry for NCT02310490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DermAvance, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Face; Atrophy appearing as the primary indexed condition, and to 2 interventions - of which DA-13-007 right with left side Sculptra left side is the first listed.
NCT02310490 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Florida, Indiana, Washington.
Frequently Asked Questions
What is clinical trial NCT02310490 about?
NCT02310490 is a clinical study titled "DA-13-007 Versus Sculptra for the Treatment of Nasolabial Folds Wrinkles". Study DA-13-007 is a randomized, evaluator-blinded, within subject (split face) multicenter clinical study of DA-13-007l (Injectable poly-l-lactic acid) compared to SCULPTRA in the treatment of nasolabial fold wrinkles. Qualifying subjects will be randomized to receive DA-13-007l and SCULPTRA on eit...
What is the current status of trial NCT02310490?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2015-01. Estimated completion is 2018-12.
What conditions does trial NCT02310490 study?
This clinical trial studies the following conditions: Face; Atrophy.
What interventions are being tested in trial NCT02310490?
The interventions under investigation include: DA-13-007 right with left side Sculptra left side (DEVICE), DA-13-007 left with left side Sculptra right side (DEVICE).
Who is sponsoring clinical trial NCT02310490?
This trial is sponsored by DermAvance, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02310490 being conducted?
This trial has 4 study locations across Florida, Indiana, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.